MRPL51
gene geneOn this page
Also known as CDA09HSPC241bMRP64mL51
Summary
MRPL51 (mitochondrial ribosomal protein L51, HGNC:14044) is a protein-coding gene on chromosome 12p13.31, encoding Large ribosomal subunit protein mL51 (Q4U2R6). It is a selective cancer dependency (DepMap: 29.3% of cell lines).
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein. Pseudogenes corresponding to this gene are found on chromosomes 4p and 21q.
Source: NCBI Gene 51258 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 32 total
- Cancer dependency (DepMap): dependent in 29.3% of screened cell lines
- MANE Select transcript:
NM_016497
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14044 |
| Approved symbol | MRPL51 |
| Name | mitochondrial ribosomal protein L51 |
| Location | 12p13.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CDA09, HSPC241, bMRP64, mL51 |
| Ensembl gene | ENSG00000111639 |
| Ensembl biotype | protein_coding |
| OMIM | 611855 |
| Entrez | 51258 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 8 protein_coding
ENST00000229238, ENST00000537701, ENST00000538814, ENST00000540949, ENST00000543164, ENST00000543703, ENST00000543959, ENST00000925507
RefSeq mRNA: 1 — MANE Select: NM_016497
NM_016497
CCDS: CCDS8547
Canonical transcript exons
ENST00000229238 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000866916 | 6493058 | 6493262 |
| ENSE00002315871 | 6491886 | 6492467 |
| ENSE00003679423 | 6492862 | 6492972 |
Expression profiles
Bgee: expression breadth ubiquitous, 263 present calls, max score 99.31.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 112.9786 / max 1861.4228, expressed in 1825 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 129103 | 98.9481 | 1824 |
| 129105 | 11.8481 | 1780 |
| 129104 | 2.1825 | 1297 |
Top tissues by expression
263 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left ventricle myocardium | UBERON:0006566 | 99.31 | gold quality |
| kidney epithelium | UBERON:0004819 | 99.30 | gold quality |
| right testis | UBERON:0004534 | 99.26 | gold quality |
| left testis | UBERON:0004533 | 99.25 | gold quality |
| upper arm skin | UBERON:0004263 | 99.15 | gold quality |
| ileal mucosa | UBERON:0000331 | 99.11 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 99.06 | gold quality |
| tibialis anterior | UBERON:0001385 | 98.93 | gold quality |
| myocardium | UBERON:0002349 | 98.88 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 98.64 | gold quality |
| quadriceps femoris | UBERON:0001377 | 98.55 | gold quality |
| heart left ventricle | UBERON:0002084 | 98.55 | gold quality |
| cardiac ventricle | UBERON:0002082 | 98.54 | gold quality |
| vastus lateralis | UBERON:0001379 | 98.51 | gold quality |
| deltoid | UBERON:0001476 | 98.47 | gold quality |
| islet of Langerhans | UBERON:0000006 | 98.42 | gold quality |
| testis | UBERON:0000473 | 98.42 | gold quality |
| apex of heart | UBERON:0002098 | 98.41 | gold quality |
| adult organism | UBERON:0007023 | 98.40 | gold quality |
| cardiac atrium | UBERON:0002081 | 98.38 | gold quality |
| heart | UBERON:0000948 | 98.36 | gold quality |
| right atrium auricular region | UBERON:0006631 | 98.36 | gold quality |
| gastrocnemius | UBERON:0001388 | 98.33 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 98.31 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 98.30 | gold quality |
| muscle of leg | UBERON:0001383 | 98.28 | gold quality |
| heart right ventricle | UBERON:0002080 | 98.27 | gold quality |
| muscle tissue | UBERON:0002385 | 98.26 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 98.26 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 98.24 | gold quality |
Single-cell (SCXA)
Detected in 6 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-9467 | yes | 33.22 |
| E-CURD-122 | yes | 16.22 |
| E-GEOD-81383 | no | 531.69 |
| E-GEOD-110499 | no | 446.19 |
| E-MTAB-7037 | no | 439.54 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
8 targeting MRPL51, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-556-3P | 99.74 | 68.75 | 1203 |
| HSA-MIR-10399-5P | 99.17 | 69.87 | 2610 |
| HSA-MIR-6504-3P | 99.17 | 69.31 | 2891 |
| HSA-MIR-670-3P | 99.03 | 68.88 | 2404 |
| HSA-MIR-5088-3P | 98.29 | 66.63 | 1310 |
| HSA-MIR-3189-5P | 97.55 | 66.71 | 655 |
| HSA-MIR-4323 | 93.93 | 63.89 | 656 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 29.3% of screened cell lines.
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mrpl51 | ENSDARG00000041340 |
| mus_musculus | Mrpl51 | ENSMUSG00000030335 |
| rattus_norvegicus | Mrpl51 | ENSRNOG00000019165 |
| drosophila_melanogaster | mRpL51 | FBGN0032053 |
| caenorhabditis_elegans | WBGENE00011740 |
Protein
Protein identifiers
Large ribosomal subunit protein mL51 — Q4U2R6 (reviewed: Q4U2R6)
Alternative names: 39S ribosomal protein L51, mitochondrial, bMRP-64
All UniProt accessions (4): Q4U2R6, A0A087WU28, A0A0B4J2C1, M0R176
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Component of the mitochondrial large ribosomal subunit (mt-LSU). Mature mammalian 55S mitochondrial ribosomes consist of a small (28S) and a large (39S) subunit. The 28S small subunit contains a 12S ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial valine transfer RNA (mt-tRNA(Val)), which plays an integral structural role, and 52 different proteins. Interacts with OXA1L.
Subcellular location. Mitochondrion.
Similarity. Belongs to the mitochondrion-specific ribosomal protein mL51 family.
RefSeq proteins (1): NP_057581* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR019373 | Ribosomal_mL51 | Family |
Pfam: PF10244
UniProt features (13 total): helix 7, turn 2, transit peptide 1, chain 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
85 structures, top 30 by resolution.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7OF0 | ELECTRON MICROSCOPY | 2.2 |
| 7QI4 | ELECTRON MICROSCOPY | 2.21 |
| 8RRI | ELECTRON MICROSCOPY | 2.4 |
| 8QU5 | ELECTRON MICROSCOPY | 2.42 |
| 9OLF | ELECTRON MICROSCOPY | 2.46 |
| 7OF7 | ELECTRON MICROSCOPY | 2.5 |
| 7PO4 | ELECTRON MICROSCOPY | 2.56 |
| 6ZM6 | ELECTRON MICROSCOPY | 2.59 |
| 7O9M | ELECTRON MICROSCOPY | 2.6 |
| 7OF6 | ELECTRON MICROSCOPY | 2.6 |
| 9CN3 | ELECTRON MICROSCOPY | 2.62 |
| 7QI5 | ELECTRON MICROSCOPY | 2.63 |
| 7OF2 | ELECTRON MICROSCOPY | 2.7 |
| 7OF3 | ELECTRON MICROSCOPY | 2.7 |
| 7OF4 | ELECTRON MICROSCOPY | 2.7 |
| 9PR4 | ELECTRON MICROSCOPY | 2.77 |
| 9PRA | ELECTRON MICROSCOPY | 2.83 |
| 8ANY | ELECTRON MICROSCOPY | 2.85 |
| 6ZM5 | ELECTRON MICROSCOPY | 2.89 |
| 7QH7 | ELECTRON MICROSCOPY | 2.89 |
| 7ODR | ELECTRON MICROSCOPY | 2.9 |
| 7OF5 | ELECTRON MICROSCOPY | 2.9 |
| 8K2A | ELECTRON MICROSCOPY | 2.9 |
| 8OIT | ELECTRON MICROSCOPY | 2.9 |
| 9PGL | ELECTRON MICROSCOPY | 2.9 |
| 9PGF | ELECTRON MICROSCOPY | 2.93 |
| 6VMI | ELECTRON MICROSCOPY | 2.96 |
| 6VLZ | ELECTRON MICROSCOPY | 2.97 |
| 7QI6 | ELECTRON MICROSCOPY | 2.98 |
| 9PSM | ELECTRON MICROSCOPY | 2.98 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q4U2R6-F1 | 86.80 | 0.71 |
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-5368286 | Mitochondrial translation initiation |
| R-HSA-5389840 | Mitochondrial translation elongation |
| R-HSA-5419276 | Mitochondrial translation termination |
| R-HSA-9937383 | Mitochondrial ribosome-associated quality control |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-5368287 | Mitochondrial translation |
| R-HSA-72766 | Translation |
MSigDB gene sets: 152 (showing top):
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, GOBP_MITOCHONDRIAL_TRANSLATION, GOBP_TRANSLATION, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1, GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME, GOCC_MITOCHONDRIAL_ENVELOPE, ACEVEDO_LIVER_CANCER_UP, BURTON_ADIPOGENESIS_6, GOCC_LARGE_RIBOSOMAL_SUBUNIT, GOCC_RIBOSOME, GCCATNTTG_YY1_Q6, GOCC_ORGANELLAR_RIBOSOME, GOCC_MITOCHONDRIAL_MATRIX, GOCC_ORGANELLE_INNER_MEMBRANE, MARSON_BOUND_BY_E2F4_UNSTIMULATED
GO Biological Process (2): translation (GO:0006412), mitochondrial translation (GO:0032543)
GO Molecular Function (2): structural constituent of ribosome (GO:0003735), protein binding (GO:0005515)
GO Cellular Component (6): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial ribosome (GO:0005761), mitochondrial large ribosomal subunit (GO:0005762), ribosome (GO:0005840), ribonucleoprotein complex (GO:1990904)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial translation | 4 |
| Translation | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| peptidyltransferase activity | 1 |
| translational initiation | 1 |
| translational elongation | 1 |
| translational termination | 1 |
| macromolecule biosynthetic process | 1 |
| protein metabolic process | 1 |
| protein biosynthetic process | 1 |
| mitochondrion | 1 |
| translation | 1 |
| mitochondrial gene expression | 1 |
| structural molecule activity | 1 |
| ribosome | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| organellar ribosome | 1 |
| mitochondrial matrix | 1 |
| organellar large ribosomal subunit | 1 |
| mitochondrial ribosome | 1 |
| mitochondrial protein-containing complex | 1 |
| intracellular membraneless organelle | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
1530 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MRPL51 | MRPL48 | Q96GC5 | 710 |
| MRPL51 | MRPL49 | Q13405 | 692 |
| MRPL51 | MRPL20 | Q9BYC9 | 689 |
| MRPL51 | MRPS21 | P82921 | 625 |
| MRPL51 | MRPS25 | P82663 | 624 |
| MRPL51 | MRPL55 | Q7Z7F7 | 614 |
| MRPL51 | NDUFA1 | O15239 | 591 |
| MRPL51 | MRPS14 | O60783 | 525 |
| MRPL51 | MRPS18C | Q9Y3D5 | 522 |
| MRPL51 | MRPL50 | Q8N5N7 | 510 |
| MRPL51 | ZSWIM7 | Q19AV6 | 493 |
| MRPL51 | MRPS30 | Q9NP92 | 493 |
| MRPL51 | PPP4R3B | Q5MIZ7 | 490 |
| MRPL51 | COA5 | Q86WW8 | 479 |
| MRPL51 | GCSH | P23434 | 474 |
IntAct
90 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MRPL37 | HSPD1 | psi-mi:“MI:0914”(association) | 0.710 |
| MRPS30 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.640 |
| MRPL50 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| RPL18 | NOP56 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL10 | ZZEF1 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL42 | GATC | psi-mi:“MI:0914”(association) | 0.530 |
| PDGFB | DKC1 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL41 | MRPL3 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL13 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL18 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| NDUFAB1 | MIEF1 | psi-mi:“MI:0915”(physical association) | 0.490 |
| MRPL50 | MRPL43 | psi-mi:“MI:0914”(association) | 0.350 |
| MRPL9 | MRPL43 | psi-mi:“MI:0914”(association) | 0.350 |
| FOXB1 | DDX39A | psi-mi:“MI:0914”(association) | 0.350 |
| HSCB | RBP5 | psi-mi:“MI:0914”(association) | 0.350 |
| HIF1AN | ARID1A | psi-mi:“MI:0914”(association) | 0.350 |
| ALYREF | psi-mi:“MI:0914”(association) | 0.350 | |
| MRPL4 | ZSWIM8 | psi-mi:“MI:0914”(association) | 0.350 |
| MRPL12 | psi-mi:“MI:0914”(association) | 0.350 | |
| RPS8 | RRP8 | psi-mi:“MI:0914”(association) | 0.350 |
| MRPL39 | PTCD1 | psi-mi:“MI:0914”(association) | 0.350 |
| MRPL47 | MRPL33 | psi-mi:“MI:0914”(association) | 0.350 |
| ATAD3A | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| PSME3 | C11orf98 | psi-mi:“MI:0914”(association) | 0.350 |
| rl36a_rl36l_human | IPO5 | psi-mi:“MI:0914”(association) | 0.350 |
| H1-7 | psi-mi:“MI:0914”(association) | 0.350 | |
| PIPSL | C1orf226 | psi-mi:“MI:0914”(association) | 0.350 |
| S100A2 | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 |
| FTL | SH3PXD2B | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (189): MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Co-fractionation), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS)
ESM2 similar proteins: A1TYV1, A3M7E7, A4SHF6, A7HUX6, A7IDK1, A8IM57, A9HHS1, A9L948, B0VBX6, B0VUE9, B1VFG4, B2HVM2, B2ICM8, B4RYA0, B6INQ0, B7GZ34, B7I4A2, B8EK30, B8H4M5, C1D0Z8, G2TRQ8, O14187, P00129, P16135, P90993, Q02950, Q15N51, Q1GDB7, Q22438, Q28GD1, Q29PG4, Q2G8J9, Q2RVH2, Q4U2R6, Q5BJJ8, Q5FNB8, Q5ZKG1, Q61SE7, Q66KZ3, Q6CAD1
Diamond homologs: P0C2B6, Q28GD1, Q29PG4, Q4U2R6, Q5BJJ8, Q5ZKG1, Q66KZ3, Q9CPY1, Q9VLJ9, Q22438, Q61SE7
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MRPL51 | “form complex” | “39S mitochondrial large ribosomal subunit” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 95 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Mitochondrial ribosome-associated quality control | 25 | 48.7× | 6e-35 |
| Mitochondrial translation initiation | 23 | 46.3× | 9e-32 |
| Mitochondrial translation elongation | 23 | 46.3× | 9e-32 |
| Mitochondrial translation | 21 | 45.9× | 6e-29 |
| Mitochondrial translation termination | 23 | 40.1× | 3e-30 |
| Translation | 22 | 21.7× | 9e-23 |
| Regulation of expression of SLITs and ROBOs | 6 | 6.6× | 6e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| mitochondrial translation | 25 | 52.3× | 1e-34 |
| translation | 18 | 22.3× | 2e-17 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
32 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 21 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
421 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:6492857:CTTA:C | donor_loss | 1.0000 |
| 12:6492858:TTAC:T | donor_loss | 1.0000 |
| 12:6492859:TA:T | donor_loss | 1.0000 |
| 12:6492860:A:AC | donor_gain | 1.0000 |
| 12:6492860:A:AG | donor_loss | 1.0000 |
| 12:6492860:AC:A | donor_gain | 1.0000 |
| 12:6492861:C:CC | donor_gain | 1.0000 |
| 12:6492861:CC:C | donor_gain | 1.0000 |
| 12:6492970:CAC:C | acceptor_gain | 1.0000 |
| 12:6492971:ACC:A | acceptor_loss | 1.0000 |
| 12:6492973:C:CA | acceptor_loss | 1.0000 |
| 12:6492974:T:G | acceptor_loss | 1.0000 |
| 12:6493362:T:TA | donor_gain | 1.0000 |
| 12:6492468:C:CA | acceptor_loss | 0.9900 |
| 12:6492468:C:CC | acceptor_gain | 0.9900 |
| 12:6492469:T:G | acceptor_loss | 0.9900 |
| 12:6492470:G:GC | acceptor_gain | 0.9900 |
| 12:6492968:CACAC:C | acceptor_gain | 0.9900 |
| 12:6492969:ACAC:A | acceptor_gain | 0.9900 |
| 12:6492970:CACC:C | acceptor_gain | 0.9900 |
| 12:6492973:C:CC | acceptor_gain | 0.9900 |
| 12:6492979:A:AC | acceptor_gain | 0.9900 |
| 12:6493343:C:A | donor_gain | 0.9900 |
| 12:6493347:T:TA | donor_gain | 0.9900 |
| 12:6493348:C:A | donor_gain | 0.9900 |
| 12:6493463:T:A | donor_gain | 0.9900 |
| 12:6493826:G:GT | donor_gain | 0.9900 |
| 12:6492463:GTTTC:G | acceptor_gain | 0.9800 |
| 12:6492464:TTTC:T | acceptor_gain | 0.9800 |
| 12:6492465:TTC:T | acceptor_gain | 0.9800 |
AlphaMissense
839 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:6492423:A:G | W79R | 0.993 |
| 12:6492423:A:T | W79R | 0.993 |
| 12:6492389:C:G | R90P | 0.992 |
| 12:6492376:C:A | K94N | 0.989 |
| 12:6492376:C:G | K94N | 0.989 |
| 12:6492913:A:G | W47R | 0.989 |
| 12:6492913:A:T | W47R | 0.989 |
| 12:6492380:C:G | R93P | 0.988 |
| 12:6492867:A:G | I62T | 0.987 |
| 12:6492879:T:A | D58V | 0.984 |
| 12:6492890:G:C | F54L | 0.983 |
| 12:6492890:G:T | F54L | 0.983 |
| 12:6492892:A:G | F54L | 0.983 |
| 12:6492878:G:C | D58E | 0.981 |
| 12:6492878:G:T | D58E | 0.981 |
| 12:6492879:T:G | D58A | 0.981 |
| 12:6492888:C:T | G55E | 0.981 |
| 12:6492290:C:G | R123P | 0.980 |
| 12:6492395:A:G | L88S | 0.980 |
| 12:6492411:A:G | W83R | 0.980 |
| 12:6492411:A:T | W83R | 0.980 |
| 12:6492911:C:A | W47C | 0.980 |
| 12:6492911:C:G | W47C | 0.980 |
| 12:6492419:A:T | L80H | 0.979 |
| 12:6492320:C:G | R113P | 0.976 |
| 12:6492421:C:A | W79C | 0.976 |
| 12:6492421:C:G | W79C | 0.976 |
| 12:6492329:A:G | L110P | 0.975 |
| 12:6492419:A:G | L80P | 0.975 |
| 12:6492467:C:A | G64V | 0.975 |
dbSNP variants (sampled 300 via entrez): RS1001090844 (12:6491647 C>G), RS1001125 (12:6492808 T>C), RS1001126 (12:6492736 A>G), RS1001127 (12:6492577 A>C,T), RS1001266777 (12:6493647 G>A,T), RS1001297938 (12:6493411 C>A,T), RS1002324800 (12:6492466 T>A,G), RS1002986437 (12:6494756 G>A,C,T), RS1003331385 (12:6493622 C>T), RS1003614727 (12:6494735 T>A), RS1003645862 (12:6494423 C>T), RS1003862728 (12:6494853 C>T), RS1005525257 (12:6493669 G>A), RS1005663579 (12:6492575 G>A,C), RS1006014178 (12:6493835 G>A,T)
Disease associations
OMIM: gene MIM:611855 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Leflunomide | decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| bisphenol F | affects cotreatment, increases expression | 1 |
| dicrotophos | decreases expression | 1 |
| beta-lapachone | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| chloropicrin | increases expression | 1 |
| K 7174 | decreases expression | 1 |
| ICG 001 | increases expression | 1 |
| Acetaminophen | affects cotreatment, decreases expression | 1 |
| Air Pollutants, Occupational | decreases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Lead | affects expression | 1 |
| Lipopolysaccharides | affects cotreatment, decreases expression | 1 |
| Nickel | decreases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Thiram | decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.